METTL16 and hepatocellular carcinoma: Therefore, these data show that the oncogenic roles of METTL16 in HCC were reversed by RAB11B-AS1, and suggest that the downregulation of RAB11B-AS1 at least partially mediated the oncogenic roles of METTL16 in HCC.